Lupin announced Thursday that it will acquire Gavis Pharmaceuticals and Novel Laboratories in a $880 million, cash- and debt-free transaction.
Novartis will be able to introduce Sandoz’s Zarxio (filgrastim) after Sept. 2, the U.S. Court of Appeal for the Federal Circuit ruled Wednesday.
Aurobindo Pharma announced Tuesday that the Food and Drug Administration had approved its generic version of Tambocor in 50-, 100- and 150-mg dosage strengths
According to NCPA CEO Douglas Hoey, independents dispensing generic medicines at a loss is not a sustainable business model.
Access to healthcare drove 82.9% more blood pressure screenings and 26.9% more diabetes screenings.
Patients surfing the content on Elsevier's Health Library can search by a specific condition or diagnosis or move through an easy-to-skim, A-to-Z list of healthcare topics.
Amneal Pharmaceuticals has introduced four new products since June.
The Trans-Pacific Partnership is setting a precedent that effectively can't be rolled back in the future, according to Congress leaders who hosted a press conference Friday morning.
Injectable and infusion drug company Hospira announced Thursday that the Food and Drug Administration had approved its bivalirudin injection, a generic of the Medicine Company’s Angiomax.
As many as 12% of pet owners have bought health insurance for their animals. And among millennials, that number jumps to 19%.